1983
DOI: 10.1016/0014-4886(83)90166-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

1987
1987
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(14 citation statements)
references
References 16 publications
0
13
0
Order By: Relevance
“…Relief of pain is rewarding [26,96,97]. Dennis and Melzack demonstrated that dopaminergic agents improve symptoms of pain and promote analgesia [98]. Studies have also shown that the VTA sends projections to the nucleus accumbens (NCs), limbic system (e.g., hippocampus and amygdala), and prefrontal cortex (e.g., mPFC, ACC, and OFC), forming the mesocorticolimbic system [27][28][29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…Relief of pain is rewarding [26,96,97]. Dennis and Melzack demonstrated that dopaminergic agents improve symptoms of pain and promote analgesia [98]. Studies have also shown that the VTA sends projections to the nucleus accumbens (NCs), limbic system (e.g., hippocampus and amygdala), and prefrontal cortex (e.g., mPFC, ACC, and OFC), forming the mesocorticolimbic system [27][28][29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…There are several potential mechanisms underlying the pathophysiological connection between TTH and PD. First, dopamine has been suggested to play a critical role in central pain modulation [ 28 ], and human neuroimaging studies have shown that pain processing involves dopamine D2 receptors [ 29 ]. Additionally, dopamine may modulate pain at different levels of pain processing, such as the spinal cord, thalamus, peri-aqueductal gray matter, basal ganglia, and cingulate gyrus [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The association between mesolimbic circuitry and neural substrates of pain and analgesia has been considered in the past decades [29; 37; 53]; for noxious or aversive conditions both excitatory and inhibitory responses of dopaminergic neurons have been observed [16; 23; 43; 50; 62; 68], both increases and decreases in extracellular dopamine are reported [11; 51], and corresponding results are found in human studies [44; 46]. Moreover, in patients with central disorders such as schizophrenia, Parkinson’s disease, substance abuse, and mood and anxiety disorders, pain sensitivity is altered, presumably as a consequence of changes in the dopaminergic system [1; 42; 71], and animal studies implicate dopamine in acute and neuropathic conditions [6; 26; 60]. Yet, the mechanistic role of NAc in pain chronification remains unknown.…”
Section: Introductionmentioning
confidence: 85%